FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898826405> ?p ?o ?g. }

• W2898826405 endingPage "249.e2" @default.
• W2898826405 startingPage "245" @default.
• W2898826405 abstract "Objective To compare the efficacy of a breath-enhanced and a conventional jet nebulizer in the treatment of children with moderate to severe acute asthma. Study design We enrolled subjects between 6 and 18 years of age presenting to the emergency department (ED) with acute asthma and an initial forced expiratory volume in 1 second (FEV1) <70% of predicted. We excluded patients with chronic disease, who required immediate resuscitation, or failed spirometry. Subjects were randomized to breath-enhanced or conventional jet delivery of a 5-mg albuterol treatment. Our primary outcome was change in FEV1, and secondary outcomes included change in clinical asthma scores, ED length of stay, disposition, and side effects. Student t test and multivariable linear regression were used to evaluate the primary outcome. Results In total, 497 patients were assessed for eligibility with 118 enrolled and 107 subjects available for analysis of the primary outcome. Improvement in FEV1 was significantly greater with conventional jet nebulizer (mean ΔFEV1 +13.8% vs +9.1%, P = .04). This difference remained significant after adjustment for baseline differences. Subgroup analysis of 57 subjects with spirometry meeting American Thoracic Society/European Respiratory Society guidelines yielded similar results (mean ΔFEV1 +14.5% vs +8.5%, P=.03). There were no significant differences in clinical asthma scores, ED length of stay, disposition, or side effects. Conclusions Albuterol delivered via conventional jet nebulizer resulted in significantly greater improvement in FEV1 than albuterol delivered by breath-enhanced nebulizer, without significant differences in clinical measures. Conventional jet nebulizers may deliver albuterol to children with acute asthma more effectively than breath-enhanced nebulizers. Trial registration ClinicalTrials.gov: NCT02566902. To compare the efficacy of a breath-enhanced and a conventional jet nebulizer in the treatment of children with moderate to severe acute asthma. We enrolled subjects between 6 and 18 years of age presenting to the emergency department (ED) with acute asthma and an initial forced expiratory volume in 1 second (FEV1) <70% of predicted. We excluded patients with chronic disease, who required immediate resuscitation, or failed spirometry. Subjects were randomized to breath-enhanced or conventional jet delivery of a 5-mg albuterol treatment. Our primary outcome was change in FEV1, and secondary outcomes included change in clinical asthma scores, ED length of stay, disposition, and side effects. Student t test and multivariable linear regression were used to evaluate the primary outcome. In total, 497 patients were assessed for eligibility with 118 enrolled and 107 subjects available for analysis of the primary outcome. Improvement in FEV1 was significantly greater with conventional jet nebulizer (mean ΔFEV1 +13.8% vs +9.1%, P = .04). This difference remained significant after adjustment for baseline differences. Subgroup analysis of 57 subjects with spirometry meeting American Thoracic Society/European Respiratory Society guidelines yielded similar results (mean ΔFEV1 +14.5% vs +8.5%, P=.03). There were no significant differences in clinical asthma scores, ED length of stay, disposition, or side effects. Albuterol delivered via conventional jet nebulizer resulted in significantly greater improvement in FEV1 than albuterol delivered by breath-enhanced nebulizer, without significant differences in clinical measures. Conventional jet nebulizers may deliver albuterol to children with acute asthma more effectively than breath-enhanced nebulizers." @default.
• W2898826405 created "2018-11-09" @default.
• W2898826405 creator A5021524601 @default.
• W2898826405 creator A5075420573 @default.
• W2898826405 date "2019-01-01" @default.
• W2898826405 modified "2023-09-26" @default.
• W2898826405 title "Randomized Clinical Trial Comparing Breath-Enhanced to Conventional Nebulizers in the Treatment of Children with Acute Asthma" @default.
• W2898826405 cites W1822810175 @default.
• W2898826405 cites W1971073287 @default.
• W2898826405 cites W1975028090 @default.
• W2898826405 cites W1977163786 @default.
• W2898826405 cites W2023687905 @default.
• W2898826405 cites W2032161478 @default.
• W2898826405 cites W2038563162 @default.
• W2898826405 cites W2090108729 @default.
• W2898826405 cites W2101581059 @default.
• W2898826405 cites W2108678383 @default.
• W2898826405 cites W2113161457 @default.
• W2898826405 cites W2125078269 @default.
• W2898826405 cites W2130363761 @default.
• W2898826405 cites W2169489631 @default.
• W2898826405 cites W2176959853 @default.
• W2898826405 cites W2618121052 @default.
• W2898826405 cites W4234347340 @default.
• W2898826405 cites W4235207852 @default.
• W2898826405 cites W4235755338 @default.
• W2898826405 cites W4241079620 @default.
• W2898826405 doi "https://doi.org/10.1016/j.jpeds.2018.08.083" @default.
• W2898826405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30392872" @default.
• W2898826405 hasPublicationYear "2019" @default.
• W2898826405 type Work @default.
• W2898826405 sameAs 2898826405 @default.
• W2898826405 citedByCount "6" @default.
• W2898826405 countsByYear W28988264052020 @default.
• W2898826405 countsByYear W28988264052021 @default.
• W2898826405 countsByYear W28988264052022 @default.
• W2898826405 countsByYear W28988264052023 @default.
• W2898826405 crossrefType "journal-article" @default.
• W2898826405 hasAuthorship W2898826405A5021524601 @default.
• W2898826405 hasAuthorship W2898826405A5075420573 @default.
• W2898826405 hasConcept C126322002 @default.
• W2898826405 hasConcept C168563851 @default.
• W2898826405 hasConcept C2776042228 @default.
• W2898826405 hasConcept C2777394947 @default.
• W2898826405 hasConcept C2780333948 @default.
• W2898826405 hasConcept C2780352487 @default.
• W2898826405 hasConcept C2781018748 @default.
• W2898826405 hasConcept C42219234 @default.
• W2898826405 hasConcept C71924100 @default.
• W2898826405 hasConceptScore W2898826405C126322002 @default.
• W2898826405 hasConceptScore W2898826405C168563851 @default.
• W2898826405 hasConceptScore W2898826405C2776042228 @default.
• W2898826405 hasConceptScore W2898826405C2777394947 @default.
• W2898826405 hasConceptScore W2898826405C2780333948 @default.
• W2898826405 hasConceptScore W2898826405C2780352487 @default.
• W2898826405 hasConceptScore W2898826405C2781018748 @default.
• W2898826405 hasConceptScore W2898826405C42219234 @default.
• W2898826405 hasConceptScore W2898826405C71924100 @default.
• W2898826405 hasLocation W28988264051 @default.
• W2898826405 hasLocation W28988264052 @default.
• W2898826405 hasOpenAccess W2898826405 @default.
• W2898826405 hasPrimaryLocation W28988264051 @default.
• W2898826405 hasRelatedWork W2013725354 @default.
• W2898826405 hasRelatedWork W2025289150 @default.
• W2898826405 hasRelatedWork W2032152555 @default.
• W2898826405 hasRelatedWork W2252156554 @default.
• W2898826405 hasRelatedWork W2409785686 @default.
• W2898826405 hasRelatedWork W2618121052 @default.
• W2898826405 hasRelatedWork W2800990715 @default.
• W2898826405 hasRelatedWork W2898826405 @default.
• W2898826405 hasRelatedWork W3213929234 @default.
• W2898826405 hasRelatedWork W3217809583 @default.
• W2898826405 hasVolume "204" @default.
• W2898826405 isParatext "false" @default.
• W2898826405 isRetracted "false" @default.
• W2898826405 magId "2898826405" @default.
• W2898826405 workType "article" @default.